- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Draper Today
By the People, for the People
Bamco Inc. NY Sells 20,475 Shares of HealthEquity, Inc. $HQY
Institutional investor decreased its stake in the healthcare company
Mar. 15, 2026 at 8:35am
Got story updates? Submit your updates here. ›
Bamco Inc. NY, an institutional investor, decreased its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 2.6% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm now owns 759,525 shares of the company's stock, valued at $71,980,000.
Why it matters
This filing provides insight into the investment decisions of Bamco Inc. NY, a notable institutional investor. Changes in major shareholders' positions can impact a company's stock price and market dynamics.
The details
Bamco Inc. NY sold 20,475 shares of HealthEquity, Inc. during the 3rd quarter, reducing its stake in the company to 759,525 shares. HealthEquity is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States.
- The filing covers Bamco Inc. NY's holdings as of the end of the 3rd quarter.
The players
Bamco Inc. NY
An institutional investor that decreased its stake in HealthEquity, Inc.
HealthEquity, Inc.
A leading administrator of consumer-directed health accounts and related benefit solutions in the United States.
The takeaway
This filing highlights the changing investment landscape around HealthEquity, as a major institutional investor reduced its position in the company. Investors may want to monitor HealthEquity's stock performance and any further changes in institutional ownership.


